glp 1 signaling New Insights into Beta-Cell GLP-1 Receptor and cAMP The role of glucagon-like peptide-1/GLP-1R

An observational study published in 2023 in Diabetes Care that looked to determine whether the use of GLP-1 medications was associated with an increased risk of thyroid cancer found that in 1-3 years of treatment, the risk for thyroid cancer was increased for those taking GLP-1 medications (2)

Dietary fat intake, pesticide use, and Parkinsons disease

Both BPC-157 and TB-500 are currently under review by the FDA's Pharmacy Compounding Advisory Committee (PCAC) , with a formal advisory panel evaluation scheduled for July 2324, 2026

Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study

GLP-1 drugs could be different, but were not there yet